|
1
|
Arvizo RR, Bhattacharyya S, Kudgus RA,
Giri K, Bhattacharya R and Mukherjee P: Intrinsic therapeutic
applications of noble metal nanoparticles: Past, present and
future. Chem Soc Rev. 41:2943–2970. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dreaden EC, Alkilany AM, Huang X, Murphy
CJ and El-Sayed MA: The golden age: Gold nanoparticles for
biomedicine. Chem Soc Rev. 41:2740–2779. 2012. View Article : Google Scholar
|
|
3
|
Dykman LA and Khlebtsov NG: Gold
nanoparticles in biology and medicine: Recent advances and
prospects. Acta Naturae. 3:34–55. 2011.PubMed/NCBI
|
|
4
|
Huang X, Jain PK, El-Sayed IH and El-Sayed
MA: Gold nanoparticles: Interesting optical properties and recent
applications in cancer diagnostics and therapy. Nanomedicine
(Lond). 2:681–693. 2007. View Article : Google Scholar
|
|
5
|
Giljohann DA, Seferos DS, Daniel WL,
Massich MD, Patel PC and Mirkin CA: Gold nanoparticles for biology
and medicine. Angew Chem Int Ed Engl. 49:3280–3294. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dreaden EC, Mackey MA, Huang X, Kang B and
El-Sayed MA: Beating cancer in multiple ways using nanogold. Chem
Soc Rev. 40:3391–3404. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arvizo RR, Saha S, Wang E, Robertson JD,
Bhattacharya R and Mukherjee P: Inhibition of tumor growth and
metastasis by a self-therapeutic nanoparticle. Proc Natl Acad Sci
USA. 110:6700–6705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Palui G, Aldeek F, Wang W and Mattoussi H:
Strategies for interfacing inorganic nanocrystals with biological
systems based on polymer-coating. Chem Soc Rev. 44:193–227. 2015.
View Article : Google Scholar
|
|
9
|
Hauser CA, Maurer-Stroh S and Martins IC:
Amyloid-based nanosensors and nanodevices. Chem Soc Rev.
43:5326–5345. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alkilany AM and Murphy CJ: Toxicity and
cellular uptake of gold nanoparticles: What we have learned so far?
J Nanopart Res. 12:2313–2333. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Connor EE, Mwamuka J, Gole A, Murphy CJ
and Wyatt MD: Gold nanoparticles are taken up by human cells but do
not cause acute cytotoxicity. Small. 1:325–327. 2005. View Article : Google Scholar
|
|
12
|
Liu Z, Wu Y, Guo Z, Liu Y, Shen Y, Zhou P
and Lu X: Effects of internalized gold particles with respect to
cytotoxicity and invasion activity in lung cancer cells. PLoS One.
9:e991752014. View Article : Google Scholar
|
|
13
|
Ju D, Sun D, Xiu L, Meng X, Zhang C and
Wei P: Interleukin-8 is associated with adhesion, migration and
invasion in human gastric cancer SCG-7901 cells. Med Oncol.
29:91–99. 2012. View Article : Google Scholar
|
|
14
|
Machens A and Dralle H: Follicular thyroid
carcinoma: Metastasis to the sternum or adjacent tumour invasion by
continuity? Int J Clin Pract. 61:5212007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cvejic DS, Savin SB, Petrovic IM, Paunovic
IR, Tatic SB and Havelka MJ: Galectin-3 expression in papillary
thyroid carcinoma: Relation to histomorphologic growth pattern,
lymph node metastasis, extrathyroid invasion, and tumor size. Head
Neck. 27:1049–1055. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liang H, Zhong Y, Luo Z, Huang Y, Lin H,
Luo M, Zhan S, Xie K, Ma Y and Li QQ: Assessment of biomarkers for
clinical diagnosis of papillary thyroid carcinoma with distant
metastasis. Int J Biol Markers. 25:38–45. 2010.PubMed/NCBI
|
|
17
|
Liang H, Zhong Y, Luo Z, Huang Y, Lin H,
Zhan S, Xie K and Li QQ: Diagnostic value of 16 cellular tumor
markers for metastatic thyroid cancer: An immunohistochemical
study. Anticancer Res. 31:3433–3440. 2011.PubMed/NCBI
|
|
18
|
Mlika M, Makhlouf C, Boudaya MS, Haddouchi
C, Tritar F and Mezni F: Evaluation of the microvessel density and
the expression of metalloproteases 2 and 9 and ttf1 in the
different subtypes of lung adenocarcinoma in Tunisia: A
retrospective study of 46 cases. J Immunoassay Immunochem.
36:111–118. 2015. View Article : Google Scholar
|
|
19
|
Sun C, Li Q, Hu Z, He J, Li C, Li G, Tao X
and Yang A: Treatment and prognosis of anaplastic thyroid
carcinoma: Experience from a single institution in China. PLoS One.
8:e800112013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
GF: Controlled nucleation for the
regulation of the particle size in monodisperse gold suspensions.
Nature. 241:20–22. 1973.
|
|
21
|
Cikos S, Bukovská A and Koppel J: Relative
quantification of mRNA: Comparison of methods currently used for
real-time PCR data analysis. BMC Mol Biol. 8:1132007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khlebtsov N and Dykman L: Biodistribution
and toxicity of engineered gold nanoparticles: A review of in vitro
and in vivo studies. Chem Soc Rev. 40:1647–1671. 2011. View Article : Google Scholar
|
|
23
|
Mesbahi A: A review on gold nanoparticles
radiosensitization effect in radiation therapy of cancer. Rep Pract
Oncol Radiother. 15:176–180. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Levy R, Shaheen U, Cesbron Y and Sée V:
Gold nanoparticles delivery in mammalian live cells: A critical
review. Nano Rev. 1:2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang S, Gao H and Bao G: Physical
principles of nanoparticle cellular endocytosis. ACS Nano.
9:8655–8671. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Oh N and Park JH: Endocytosis and
exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine.
9(Suppl 1): 51–63. 2014.PubMed/NCBI
|
|
27
|
Arvizo R, Bhattacharya R and Mukherjee P:
Gold nanoparticles: Opportunities and challenges in nanomedicine.
Expert Opin Drug Deliv. 7:753–763. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cui W, Li J, Zhang Y, Rong H, Lu W and
Jiang L: Effects of aggregation and the surface properties of gold
nanoparticles on cytotoxicity and cell growth. Nanomedicine.
8:46–53. 2012. View Article : Google Scholar
|
|
29
|
Patra HK, Banerjee S, Chaudhuri U, Lahiri
P and Dasgupta AK: Cell selective response to gold nanoparticles.
Nanomedicine. 3:111–119. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thakor AS, Paulmurugan R, Kempen P,
Zavaleta C, Sinclair R, Massoud TF and Gambhir SS: Oxidative stress
mediates the effects of Raman-active gold nanoparticles in human
cells. Small. 7:126–136. 2011. View Article : Google Scholar
|
|
31
|
Pan Y, Leifert A, Ruau D, Neuss S,
Bornemann J, Schmid G, Brandau W, Simon U and Jahnen-Dechent W:
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative
stress and mitochondrial damage. Small. 5:2067–2076. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang Y, Qu Y and Lü X: Global gene
expression analysis of the effects of gold nanoparticles on human
dermal fibroblasts. J Biomed Nanotechnol. 6:234–246. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hamano Y, Zeisberg M, Sugimoto H, Lively
JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A and Kalluri R:
Physiological levels of tumstatin, a fragment of collagen IV alpha3
chain, are generated by MMP-9 proteolysis and suppress angiogenesis
via alphaV beta3 integrin. Cancer Cell. 3:589–601. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Egeblad M and Werb Z: New functions for
the matrix metal-loproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Borrello MG, Alberti L, Fischer A,
Degl'innocenti D, Ferrario C, Gariboldi M, Marchesi F, Allavena P,
Greco A, Collini P, et al: Induction of a proinflammatory program
in normal human thyrocytes by the RET/PTC1 oncogene. Proc Natl Acad
Sci USA. 102:14825–14830. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mesa C Jr, Mirza M, Mitsutake N, Sartor M,
Medvedovic M, Tomlinson C, Knauf JA, Weber GF and Fagin JA:
Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells
is associated with gene expression profiles that predict a
preferential role of BRAF in extracellular matrix remodeling.
Cancer Res. 66:6521–6529. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sanii S, Saffar H, Tabriz HM, Qorbani M,
Haghpanah V and Tavangar SM: Expression of matrix
metalloproteinase-2, but not caspase-3, facilitates distinction
between benign and malignant thyroid follicular neoplasms. Asian
Pac J Cancer Prev. 13:2175–2178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Delektorskaia VV, Smirnova EA, Ponomareva
MV, Pavlova TV and Pavlov IA: Expression of matrix
metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in
papillary thyroid cancer: An association with the clinical,
morphological and ultrastructural characteristics of a tumor. Arkh
Patol. 72:3–6. 2010.In Russian. PubMed/NCBI
|
|
39
|
Marecko I, Cvejić D, Tatić S, Dragutinović
V, Paunović I and Savin S: Expression of matrix metalloproteinase-2
and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue
and their significance as diagnostic and prognostic markers in
papillary carcinoma. Cancer Biomark. 11:49–58. 2011.PubMed/NCBI
|
